PDP1 related ferroptosis risk signature indicates distinct immune microenvironment and prognosis of breast cancer patients
RiskScore model constructed by <i>PDP1</i>-ferroptosis-related genes <i>ACSL1</i>, <i>BNIP3</i>, and <i>EMC2</i> is able to help predict the prognosis of BC patients.
Authors
- Yingxia Tian (ORCID: https://orcid.org/0000-0003-0693-3031)
- Gongjian Zhu (ORCID: https://orcid.org/0000-0001-5298-9699)
- Yufeng Wang (ORCID: https://orcid.org/0000-0002-4576-1984)
- Huifen Dang
Institutions
- Gansu Provincial Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-04-23
- DOI
- https://doi.org/10.3389/fphar.2025.1551325
- Citations
- 1
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- National Science Foundation